In accordance with the current EU data protection laws, please take a minute to review our privacy rules, which describe how we use the data generated during your visit and the options available to you.
About
Genome engineering through CRISPR/Cas is offering many new and exciting possibilities for cancer research as well as opening up potential clinical applications.
To assist with the implementation of this state-of-the-art technology, Cancer Center Amsterdam (CCA) has appointed a CRISPR Consultant (crispr@amsterdamumc.nl) to assist CCA researchers with anything related to CRISPR/Cas. The CRISPR Consultant organizes meetings and a course for researchers interested in CRISPR and hosts an online community harboring lists of available reagents and protocols. The Consultant also assists with the design, optimization and implementation of CRISPR/Cas-related protocols and applications.
The CRISPR Platform is governed by Louis Vermeulen (https://vermeulenlab.org) and Rob Wolthuis (http://www.oncogenetics.nl).